Karkinos is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer.
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Investment with representation on the Board of Directors and technical know-how
The target demographic will be those between the ages of 30 and 65 years
This strategic collaboration will enable continued innovation in cancer care
Karkinos Healthcare has demonstrated exceptional dedication to privacy, setting a commendable example for businesses navigating the complexities of the digital landscape
Marks the World Head & Neck Cancer Day at the OCTF Conference
With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)
To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform
Subscribe To Our Newsletter & Stay Updated
